共 8 条
[1]
Utility of endothelin-converting enzyme inhibitors forthe treatment of cardiovascular disease. Jeng AY. Curr Opin InvestigDrugs . 2003
[2]
Alterations of endothelin-converting enzyme expression in early and advanced stages ofhuman coronary atherosclerosis. Hai E,Ikura Y,Naruko T,et al. International Journal of Molecular Medicine . 2004
[3]
AngiotensinⅡacti-vates collagen typeⅠgene in the renal cortex and aorta oftransgenic mice through interaction with endothelin and TGF-β. Fakhouri F,Placier S,Ardaillou R,et al. Journal of the American Society of Nephrology . 2001
[4]
The pathogenesis of atherosclerosis:a perspective forthe 1990s. Ross R. Nature . 1993
[5]
Plasma immunoreac-tive endothelin,but not thrombomodulin,is increased in pa-tients with essential hypertension and ischemic heart disease. Naruse M,Kawana M,Hifumi S,et al. J Cardiovasc Pharmacol,1991 .
[6]
VSM growth is stimulated in sympathetic neuron/VSM cocultures:role of TGF-β2 and endothelin. Damon DH. American Journal of Physiology Heart and Circulatory Physiology . 2000
[7]
Expression of endothe-lin-1,endothelin-3,endothelin-converting enzyme-1 and endo-thelin-A and endothelin-B receptor mRNA after angioplasty in-duced neointimal formation in the rat. Wang X,Douglas SA,Louden C,et al. Circulation Research . 1996
[8]
Endothelin-1 andendothelin converting enzyme-1 in human atherosclerosis-noveltargets for pharmacotherapy in atherosclerosis. Ihling C,Bohrmann B,Schaefer HE,et al. Curr VascPharmacol . 2004